Perspectives On Side Effect Management Strategies With Pirfenidone And Nintedanib

Safety and Management of Side Effects of Pirfenidone and Nintedanib | Wendi Mason, MSN

Pulmonary Fibrosis Foundation

Pirfenidone and Nintedanib Tips for Treating Patients with Idiopathic Pulmonary

Bolton Pulmonary Fibrosis Support Group

Choosing NOT to take antifibrotic medication

Interstitial Lung Disease Info

Overview of Pirfenidone and Nintedanib | Joyce Lee, MD

Pulmonary Fibrosis Foundation

Current Perspective on Antifibrotic Therapy for Patients with IPF

The France Foundation

Treatment Part B: Adverse Reactions Pirfenidone & Nintedanib - Interstitial Lung Disease

Annenberg Center for Health Sciences

What are the side effects of Ofev Nintedanib

Impact Of Patient Education And Follow Up With Pirfenidone In Patients With IPF

The France Foundation

Pharmacologic Therapy | Charlene Fell, MD, MSc

Pulmonary Fibrosis Foundation

Nice Update on Nintedanib for ILD Patients Steve Jones Action for Pulmonary Fibrosis

Bolton Pulmonary Fibrosis Support Group

Antifibrotic treatment in Pulmonary Fibrosis

Dr. Stefan Cristian Stanel

The Effect of Nintedanib in IPF Subgroups

The France Foundation

IPF Treatments: Starting on Nintedanib

PlatformQ Health

Foods to Help with Side Effects from Pulmonary Fibrosis Medication

Pulmonary Fibrosis NOW!

Effect of Nintedanib in Patients With PF ILDs Further Analyses of the INBUILD Trial

The France Foundation

Food to eat and avoid with OFEV, a Meeting Moment from PF Warriors

Safety & Efficacy of Pirfenidone for IPF - Part 1

Fibrosis and Pirfenidone

Carlos Remolina

Idiopathic Pulmonary Fibrosis: Pirfenidone

Demystifying Medicine McMaster

Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease

The France Foundation